Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis

I. Virmani, A. Oteo, M. Dunn, D. Vidler, C. Roper, J. Officer, G. Hardy, PI. Dargan, M. Eddleston, JG. Cooper, SL. Hill, R. Macfarlane, L. Keating, M. Haden, S. Hudson, SHL. Thomas

. 2023 ; 61 (1) : 39-46. [pub] 20221102

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004794

CONTEXT: Acute toxicity caused by illicit substance use is a common reason for emergency department (ED) presentation. Knowledge of the substances involved is helpful for predicting and managing potential toxicity, but limited information is available about the accuracy of patient-reported substance exposure. This study assessed the accuracy of the history of exposure in those reporting use of a single substance by comparison with those identified by detailed toxicological analysis, focusing on synthetic cannabinoid receptor agonists (SCRA). METHODS: Adults (≥16 years) presenting between March 2015 and July 2021 to participating UK hospitals with toxicity after reporting use of a single illicit substance were included. Exposure details were documented from medical records and blood and/or urine samples analysed using high-resolution accurate mass liquid chromatography-mass spectrometry (HRAM LCMS). Sensitivity, specificity, and positive and negative predictive values of the exposure history were calculated by comparison with biological sample analysis ("gold standard"). RESULTS: Single substance exposure was reported for 474 (median age 33 years, IQR: 18 range 16-75, 80% males) patients. Analysis commonly identified multiple substances (Median 3, IQR 2-5). A history of exposure was documented for 121 of 151 patients where a SCRA or metabolite was detected on analysis (sensitivity 80.1%, 95% CI 72.9, 86.2%). Corresponding proportions were lower for 3,4-methylenedioxymethamphetamine (MDMA, 44/70, 62.9%., 95% CI 50.5%, 74.1%), heroin 41/108 (38.0% 95% CI 28.8-47.8%) and cocaine (22/56, 31.3%, 95% CI 20.9, 43.6%). CONCLUSIONS: Multiple undeclared substances were detected analytically in most patients reporting single substance use. Clinicians should be alert to the potential presence and toxicity of unreported substances when managing patients presenting after substance misuse.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004794
003      
CZ-PrNML
005      
20230425171725.0
007      
ta
008      
230418s2023 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/15563650.2022.2131566 $2 doi
035    __
$a (PubMed)36322622
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Virmani, Ishita $u Medical Toxicology Centre, Newcastle University, Newcastle, UK $u RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000024773164X
245    10
$a Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysis / $c I. Virmani, A. Oteo, M. Dunn, D. Vidler, C. Roper, J. Officer, G. Hardy, PI. Dargan, M. Eddleston, JG. Cooper, SL. Hill, R. Macfarlane, L. Keating, M. Haden, S. Hudson, SHL. Thomas
520    9_
$a CONTEXT: Acute toxicity caused by illicit substance use is a common reason for emergency department (ED) presentation. Knowledge of the substances involved is helpful for predicting and managing potential toxicity, but limited information is available about the accuracy of patient-reported substance exposure. This study assessed the accuracy of the history of exposure in those reporting use of a single substance by comparison with those identified by detailed toxicological analysis, focusing on synthetic cannabinoid receptor agonists (SCRA). METHODS: Adults (≥16 years) presenting between March 2015 and July 2021 to participating UK hospitals with toxicity after reporting use of a single illicit substance were included. Exposure details were documented from medical records and blood and/or urine samples analysed using high-resolution accurate mass liquid chromatography-mass spectrometry (HRAM LCMS). Sensitivity, specificity, and positive and negative predictive values of the exposure history were calculated by comparison with biological sample analysis ("gold standard"). RESULTS: Single substance exposure was reported for 474 (median age 33 years, IQR: 18 range 16-75, 80% males) patients. Analysis commonly identified multiple substances (Median 3, IQR 2-5). A history of exposure was documented for 121 of 151 patients where a SCRA or metabolite was detected on analysis (sensitivity 80.1%, 95% CI 72.9, 86.2%). Corresponding proportions were lower for 3,4-methylenedioxymethamphetamine (MDMA, 44/70, 62.9%., 95% CI 50.5%, 74.1%), heroin 41/108 (38.0% 95% CI 28.8-47.8%) and cocaine (22/56, 31.3%, 95% CI 20.9, 43.6%). CONCLUSIONS: Multiple undeclared substances were detected analytically in most patients reporting single substance use. Clinicians should be alert to the potential presence and toxicity of unreported substances when managing patients presenting after substance misuse.
650    _2
$a dospělí $7 D000328
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé $7 D006801
650    _2
$a mladiství $7 D000293
650    _2
$a mladý dospělý $7 D055815
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senioři $7 D000368
650    _2
$a ženské pohlaví $7 D005260
650    12
$a zakázané drogy $x toxicita $7 D013287
650    12
$a poruchy spojené s užíváním psychoaktivních látek $x diagnóza $x epidemiologie $7 D019966
650    _2
$a agonisté kanabinoidních receptorů $7 D063386
650    _2
$a hmotnostní spektrometrie $7 D013058
650    _2
$a urgentní služby nemocnice $7 D004636
650    _2
$a odhalování abúzu drog $x metody $7 D015813
655    _2
$a časopisecké články $7 D016428
700    1_
$a Oteo, Alberto $u Addictions and Inclusion Directorate, Department of Health and Social Care, Office for Health Improvement & Disparities, London, UK $1 https://orcid.org/0000000242399529
700    1_
$a Dunn, Michael $u Medical Toxicology Centre, Newcastle University, Newcastle, UK
700    1_
$a Vidler, Daniel $u Medical Toxicology Centre, Newcastle University, Newcastle, UK
700    1_
$a Roper, Clair $u Medical Toxicology Centre, Newcastle University, Newcastle, UK
700    1_
$a Officer, Jane $u Scottish Police Authority Forensic Services, Edinburgh, UK
700    1_
$a Hardy, Gareth $u Blackpool Teaching Hospitals NHS Foundation Trust, Blackpool, UK
700    1_
$a Dargan, Paul I $u Clinical Toxicology, Guys & St Thomas' NHS Foundation Trust, London and Faculty of Life Sciences and Medicine, King's College London, London, UK
700    1_
$a Eddleston, Michael $u Pharmacology, Toxicology & Therapeutics, University of Edinburgh, Edinburgh, UK $1 https://orcid.org/0000000268573441
700    1_
$a Cooper, Jamie G $u Aberdeen Royal Infirmary, Aberdeen, UK $1 https://orcid.org/0000000338127026
700    1_
$a Hill, Simon L $u Medical Toxicology Centre, Newcastle University, Newcastle, UK $u Newcastle Hospitals NHS Foundation Trust and National Poisons Information Service, Newcastle, UK
700    1_
$a Macfarlane, Rebecca $u Epsom and St Helier University Hospitals NHS Trust, Epsom, UK $1 https://orcid.org/0000000311214808
700    1_
$a Keating, Liza $u Royal Berkshire NHS Foundation Trust, Reading, UK $1 https://orcid.org/0000000190282520
700    1_
$a Haden, Mark $u St George's University Hospitals NHS Foundation Trust, London, UK $1 https://orcid.org/0000000211988822
700    1_
$a Hudson, Simon $u LGC Sport and Specialised Analytical Services, Fordham, UK
700    1_
$a Thomas, Simon H L $u Medical Toxicology Centre, Newcastle University, Newcastle, UK $u Newcastle Hospitals NHS Foundation Trust and National Poisons Information Service, Newcastle, UK $1 https://orcid.org/0000000205816389
773    0_
$w MED00013938 $t Clinical toxicology (Philadelphia, Pa.) $x 1556-9519 $g Roč. 61, č. 1 (2023), s. 39-46
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36322622 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171721 $b ABA008
999    __
$a ok $b bmc $g 1925091 $s 1191003
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 61 $c 1 $d 39-46 $e 20221102 $i 1556-9519 $m Clinical toxicology $n Clin Toxicol (Phila) $x MED00013938
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace